Mercer Global Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24K | Buy |
+33,415
| New | +$24K | ﹤0.01% | 2189 |
|
|
2024
Q4 | – | Sell |
-15,316
| Closed | -$61.6K | – | 2192 |
|
|
2024
Q3 | $61.6K | Sell |
15,316
-1,287
| -8% | -$5.17K | ﹤0.01% | 1907 |
|
|
2024
Q2 | $108K | Sell |
16,603
-219,620
| -93% | -$1.43M | ﹤0.01% | 1867 |
|
|
2024
Q1 | $2.06M | Sell |
236,223
-4,211
| -2% | -$36.7K | 0.01% | 719 |
|
|
2023
Q4 | $2.75M | Sell |
240,434
-4,315
| -2% | -$49.4K | 0.01% | 635 |
|
|
2023
Q3 | $2.36M | Buy |
244,749
+34,737
| +17% | +$335K | 0.01% | 649 |
|
|
2023
Q2 | $2.24M | Buy |
210,012
+20,610
| +11% | +$219K | 0.01% | 698 |
|
|
2023
Q1 | $1.99M | Buy |
189,402
+10,366
| +6% | +$109K | 0.01% | 684 |
|
|
2022
Q4 | $2.22M | Buy |
179,036
+1,906
| +1% | +$23.6K | 0.01% | 662 |
|
|
2022
Q3 | $1.84M | Buy |
177,130
+1,659
| +0.9% | +$17.2K | 0.01% | 643 |
|
|
2022
Q2 | $2.02M | Buy |
175,471
+19,422
| +12% | +$224K | 0.01% | 609 |
|
|
2022
Q1 | $1.96M | Buy |
156,049
+31,432
| +25% | +$395K | 0.01% | 653 |
|
|
2021
Q4 | $1.45M | Buy |
124,617
+63,100
| +103% | +$736K | 0.01% | 735 |
|
|
2021
Q3 | $803K | Buy |
61,517
+13,079
| +27% | +$171K | 0.01% | 965 |
|
|
2021
Q2 | $623K | Buy |
48,438
+2,550
| +6% | +$32.8K | ﹤0.01% | 1039 |
|
|
2021
Q1 | $513K | Sell |
45,888
-1,554
| -3% | -$17.4K | ﹤0.01% | 1068 |
|
|
2020
Q4 | $540K | Buy |
47,442
+10,401
| +28% | +$118K | 0.01% | 834 |
|
|
2020
Q3 | $333K | Buy |
37,041
+1,484
| +4% | +$13.3K | 0.01% | 919 |
|
|
2020
Q2 | $367K | Buy |
+35,557
| New | +$367K | 0.01% | 784 |
|